Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (641-650 of 717) with videos related to

Pageof 72
Sort By:
Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.
European Heart Journal|September 25, 2025
Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsyKana Nakashima, Takanori Yamaguchi, Yuya Takahashi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2021
Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological databaseAkira Fukui, Hidehiro Kaneko, Akira Okada, et al.
Cardiovascular Diabetology|April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trialAtsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.
Progress in Cardiovascular Diseases|December 8, 2019
Systemic hemodynamic atherothrombotic syndrome (SHATS) - Coupling vascular disease and blood pressure variability: Proposed concept from pulse of AsiaKazuomi Kario, Julio A Chirinos, Raymond R Townsend, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 5, 2022
Update on Hypertension Research in 2021Masaki Mogi, Tatsuya Maruhashi, Yukihito Higashi, et al.
European Journal of Preventive Cardiology|September 1, 2022
Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the American College of Cardiology/American Heart Association guideline and cardiovascular outcomesHidehiro Kaneko, Yuichiro Yano, Yuta Suzuki, et al.
The American Journal of Cardiology|January 22, 2022
Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure GuidelineYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
American Journal of Nephrology|March 8, 2022
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based DatabaseYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
Journal of Atherosclerosis and Thrombosis|December 21, 2025
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific ReportAtsushi Tanaka, Kazuma Oyama, Yusuke Yakushiji, et al.
Pageof 72

Showing results (641-650 of 717) with videos related to

Sort By:
Pageof 72
Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.
European Heart Journal|September 25, 2025
Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsyKana Nakashima, Takanori Yamaguchi, Yuya Takahashi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2021
Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological databaseAkira Fukui, Hidehiro Kaneko, Akira Okada, et al.
Cardiovascular Diabetology|April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trialAtsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.
Progress in Cardiovascular Diseases|December 8, 2019
Systemic hemodynamic atherothrombotic syndrome (SHATS) - Coupling vascular disease and blood pressure variability: Proposed concept from pulse of AsiaKazuomi Kario, Julio A Chirinos, Raymond R Townsend, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 5, 2022
Update on Hypertension Research in 2021Masaki Mogi, Tatsuya Maruhashi, Yukihito Higashi, et al.
European Journal of Preventive Cardiology|September 1, 2022
Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the American College of Cardiology/American Heart Association guideline and cardiovascular outcomesHidehiro Kaneko, Yuichiro Yano, Yuta Suzuki, et al.
The American Journal of Cardiology|January 22, 2022
Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure GuidelineYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
American Journal of Nephrology|March 8, 2022
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based DatabaseYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
Journal of Atherosclerosis and Thrombosis|December 21, 2025
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific ReportAtsushi Tanaka, Kazuma Oyama, Yusuke Yakushiji, et al.
Pageof 72